Ozempic, Coerced Weight-Loss, and Threats to Rationality
Over the last four years, GLP-1 agonists such as Ozempic, touted by many as miracle weight-loss drugs and popularized by...
Over the last four years, GLP-1 agonists such as Ozempic, touted by many as miracle weight-loss drugs and popularized by...
Bioethics exists to help us think clearly about difficult medical decisions, especially when those decisions affect indi...
Our research team has recently completed a pilot study with groups of older adults (N=11) and family care partners (N=9)...
My great-aunt chose medical assistance in dying (MAiD) in Alberta, Canada. It was sad – all death is – but i...
In an effort to justify the growing landscape of AI use in healthcare, there have been countless studies and empirical a...
The Department of Health and Human Services released the report, The Treatment of Pediatric Gender Dysphoria (herein ...
It’s an unfortunate reality that in medical contexts, women’s pain continues to be ignored, overlooked, or treated as an...
This editorial appears in the October 2025 issue of the American Journal of Bioethics Although AI in healthcar...
Indiana University Center for Bioethics
Vannuys Medical Science Building Room 326/OnlinePrescriptions of GLP-1 drugs to patients without diabetes have seen an increase of 700% since 2019. GLP-1 drugs like O...
This editorial appears in the June 2025 issue of the American Journal of Bioethics. Background The correct ap...
This editorial appears in the June 2025 issue of the American Journal of Bioethics. As of early March 2025, 6...